The gene polymorphisms of UCP1 but not PPAR γ and TCF7L2 are associated with diabetic retinopathy in Chinese type 2 diabetes mellitus cases

Acta Ophthalmologica

Volumn 93, Issue 3, 2015, Pages e223-e229

  Zhang, Yue ^a   Meng, Nana ^a   Lv, Zhiping ^a   Li, Hao ^a   Qu, Yi ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

diabetic retinopathy; peroxisome proliferator activated receptor ; polymorphism; transcription factor 7 like 2; uncoupling protein 1

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR 7 LIKE 2; UNCOUPLING PROTEIN 1; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN; TCF7L2 PROTEIN, HUMAN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CASE CONTROL STUDY; CHINESE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NON PROLIFERATIVE DIABETIC RETINOPATHY; PATIENT RISK; PPAR GAMMA GENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE; UCP1 GENE; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; INSULIN RESISTANCE; METABOLISM; POLYMERASE CHAIN REACTION;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD GLUCOSE; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GENE FREQUENCY; GENOTYPE; GENOTYPING TECHNIQUES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN RESISTANCE; ION CHANNELS; MALE; MIDDLE AGED; MITOCHONDRIAL PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PPAR GAMMA; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRIGLYCERIDES;

EID: 84927695550     PISSN: 1755375X     EISSN: 17553768     Source Type: Journal    
DOI: 10.1111/aos.12542     Document Type: Article

References (55)

1. Al-Kateb H, Mirea L, Xie X, et al. (2007): Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: the DCCT/EDIC genetics study. Diabetes 56: 2161-2168.
2. Altshuler D, Hirschhorn JN, Klannemark M, et al. (2000): The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26: 76-80.
3. Ballard DJ, Melton LJ 3rd, Dwyer MS, Trautmann JC, Chu CP, O'Fallon WM, &, Palumbo PJ, (1986): Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care 9: 334-342.
4. Bamba H, Ota S, Kato A, Kawamoto C, &, Fujiwara K, (2000): Prostaglandins up-regulate vascular endothelial growth factor production through distinct pathways in differentiated U937 cells. Biochem Biophys Res Commun 273: 485-491.
5. Bego T, Dujic T, Mlinar B, et al. (2011): Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes. Med Glas (Zenica) 8: 76-83.
6. Brondani LA, de Souza BM, Duarte GC, et al. (2012): The UCP1 -3826A/G polymorphism is associated with diabetic retinopathy and increased UCP1 and MnSOD2 gene expression in human retina. Invest Ophthalmol Vis Sci 53: 7449-7457.
7. Cannon B, Shabalina IG, Kramarova TV, Petrovic N, &, Nedergaard J, (2006): Uncoupling proteins: a role in protection against reactive oxygen species-or not? Biochim Biophys Acta 1757: 449-458.
8. Chiefari E, Tanyolac S, Paonessa F, et al. (2011): Functional variants of the HMGA1 gene and type 2 diabetes mellitus. JAMA 305: 903-912.
9. Chiefari E, Nevolo MT, Arcidiacono B, et al. (2012): HMGA1 is a novel downstream nuclear target of the insulin receptor signaling pathway. Sci Rep 2: 251.
10. Ciudin A, Hernandez C, &, Simo R, (2013): Molecular Implications of the PPARs in the Diabetic Eye. PPAR Res 2013: 686525.
11. Costa V, Casamassimi A, Esposito K, et al. (2009): Characterization of a novel polymorphism in PPARG regulatory region associated with type 2 diabetes and diabetic retinopathy in Italy. J Biomed Biotechnol 2009: 126917.
12. Cui Y, Xu X, Bi H, et al. (2006): Expression modification of uncoupling proteins and MnSOD in retinal endothelial cells and pericytes induced by high glucose: the role of reactive oxygen species in diabetic retinopathy. Exp Eye Res 83: 807-816.
13. Dalgaard LT, &, Pedersen O, (2001): Uncoupling proteins: functional characteristics and role in the pathogenesis of obesity and Type II diabetes. Diabetologia 44: 946-965.
14. Damcott CM, Pollin TI, Reinhart LJ, Ott SH, Shen H, Silver KD, Mitchell BD, &, Shuldiner AR, (2006): Polymorphisms in the transcription factor 7-like 2 (TCF7L2) gene are associated with type 2 diabetes in the Amish: replication and evidence for a role in both insulin secretion and insulin resistance. Diabetes 55: 2654-2659.
15. Esterbauer H, Oberkofler H, Liu YM, Breban D, Hell E, Krempler F, &, Patsch W, (1998): Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus. J Lipid Res 39: 834-844.
16. Foti D, Chiefari E, Fedele M, et al. (2005): Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 11: 765-773.
17. Francis GA, Fayard E, Picard F, &, Auwerx J, (2003): Nuclear receptors and the control of metabolism. Annu Rev Physiol 65: 261-311.
18. Grant SF, Thorleifsson G, Reynisdottir I, et al. (2006): Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38: 320-323.
19. Hadjadj S, Pean F, Gallois Y, et al. (2004): Different patterns of insulin resistance in relatives of type 1 diabetic patients with retinopathy or nephropathy: the Genesis France-Belgium Study. Diabetes Care 27: 2661-2668.
20. Hara K, Okada T, Tobe K, et al. (2000): The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes. Biochem Biophys Res Commun 271: 212-216.
21. Hayashi T, Iwamoto Y, Kaku K, Hirose H, &, Maeda S, (2007): Replication study for the association of TCF7L2 with susceptibility to type 2 diabetes in a Japanese population. Diabetologia 50: 980-984.
22. Herrmann SM, Ringel J, Wang JG, Staessen JA, &, Brand E, (2002): Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: the Berlin Diabetes Mellitus (BeDiaM) Study. Diabetes 51: 2653-2657.
23. Heude B, Pelloux V, Forhan A, Bedel JF, Lacorte JM, Clement K, &, Charles MA, (2011): Association of the Pro12Ala and C1431T variants of PPARgamma and their haplotypes with susceptibility to gestational diabetes. J Clin Endocrinol Metab 96: E1656-E1660.
24. Huguenin GV, &, Rosa G, (2010): The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects. Br J Nutr 104: 488-497.
25. Jin T, (2008): The WNT signalling pathway and diabetes mellitus. Diabetologia 51: 1771-1780.
26. Klein R, Klein BE, Moss SE, Davis MD, &, DeMets DL, (1984): The Wisconsin epidemiologic study of diabetic retinopathy II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102: 520-526.
27. Kotani K, Sakane N, Saiga K, Adachi S, Shimohiro H, Mu H, &, Kurozawa Y, (2008): Relationship between A-3826G polymorphism in the promoter of the uncoupling protein-1 gene and high-density lipoprotein cholesterol in Japanese individuals: a cross-sectional study. Arch Med Res 39: 142-146.
28. Kowluru RA, &, Abbas SN, (2003): Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci 44: 5327-5334.
29. Kurioka S, Koshimura K, Murakami Y, Nishiki M, &, Kato Y, (2000): Reverse correlation between urine nitric oxide metabolites and insulin resistance in patients with type 2 diabetes mellitus. Endocr J 47: 77-81.
30. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, &, Agardh CD, (2008): Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS ONE 3: e2546.
31. Lindi VI, Uusitupa MI, Lindstrom J, et al. (2002): Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 51: 2581-2586.
32. Ma J, Li Y, Zhou F, Xu X, Guo G, &, Qu Y, (2012): Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene and diabetic retinopathy in Caucasians and Asians. Mol Vis 18: 2352-2360.
33. Maiese K, Morhan SD, &, Chong ZZ, (2007): Oxidative stress biology and cell injury during type 1 and type 2 diabetes mellitus. Curr Neurovasc Res 4: 63-71.
34. Malecki MT, Cyganek K, Mirkiewicz-Sieradzka B, Wolkow PP, Wanic K, Skupien J, Solnica B, &, Sieradzki J, (2008): Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes. Diabetes Res Clin Pract 80: 139-145.
35. McKay R, McCarty CA, &, Taylor HR, (2000): Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br J Ophthalmol 84: 865-870.
36. Ng MC, Tam CH, Lam VK, So WY, Ma RC, &, Chan JC, (2007): Replication and identification of novel variants at TCF7L2 associated with type 2 diabetes in Hong Kong Chinese. J Clin Endocrinol Metab 92: 3733-3737.
37. Oh HH, Kim KS, Choi SM, Yang HS, &, Yoon Y, (2004): The effects of uncoupling protein-1 genotype on lipoprotein cholesterol level in Korean obese subjects. Metabolism 53: 1054-1059.
38. Petrovic MG, Kunej T, Peterlin B, Dovc P, &, Petrovic D, (2005): Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not. Diabetes Metab Res Rev 21: 470-474.
39. Poulsen P, Andersen G, Fenger M, et al. (2003): Impact of two common polymorphisms in the PPARgamma gene on glucose tolerance and plasma insulin profiles in monozygotic and dizygotic twins: thrifty genotype, thrifty phenotype, or both? Diabetes 52: 194-198.
40. Radha V, Rema M, &, Mohan V, (2002): Genes and diabetic retinopathy. Indian J Ophthalmol 50: 5-11.
41. Ringel J, Engeli S, Distler A, &, Sharma AM, (1999): Pro12Ala missense mutation of the peroxisome proliferator activated receptor gamma and diabetes mellitus. Biochem Biophys Res Commun 254: 450-453.
42. Rudofsky G Jr, Schroedter A, Schlotterer A, et al. (2006): Functional polymorphisms of UCP2 and UCP3 are associated with a reduced prevalence of diabetic neuropathy in patients with type 1 diabetes. Diabetes Care 29: 89-94.
43. Rudofsky G Jr, Schrodter A, Voron'ko OE, et al. (2007): Promoter polymorphisms of UCP1, UCP2, and UCP3 are not associated with diabetic microvascular complications in type 2 diabetes. Horm Metab Res 39: 306-309.
44. Santos KG, Tschiedel B, Schneider J, Souto K, &, Roisenberg I, (2003): Diabetic retinopathy in Euro-Brazilian type 2 diabetic patients: relationship with polymorphisms in the aldose reductase, the plasminogen activator inhibitor-1 and the methylenetetrahydrofolate reductase genes. Diabetes Res Clin Pract 61: 133-136.
45. Sassa Y, Hata Y, Aiello LP, Taniguchi Y, Kohno K, &, Ishibashi T, (2004): Bifunctional properties of peroxisome proliferator-activated receptor gamma1 in KDR gene regulation mediated via interaction with both Sp1 and Sp3. Diabetes 53: 1222-1229.
46. Singleton JR, Smith AG, Russell JW, &, Feldman EL, (2003): Microvascular complications of impaired glucose tolerance. Diabetes 52: 2867-2873.
47. Smith U, (2007): TCF7L2 and type 2 diabetes-we WNT to know. Diabetologia 50: 5-7.
48. Sramkova D, Krejbichova S, Vcelak J, et al. (2007): The UCP1 gene polymorphism A-3826G in relation to DM2 and body composition in Czech population. Exp Clin Endocrinol Diabetes 115: 303-307.
49. Stefan N, Fritsche A, Haring H, &, Stumvoll M, (2001): Effect of experimental elevation of free fatty acids on insulin secretion and insulin sensitivity in healthy carriers of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene. Diabetes 50: 1143-1148.
50. Trudeau K, Molina AJ, &, Roy S, (2011): High glucose induces mitochondrial morphology and metabolic changes in retinal pericytes. Invest Ophthalmol Vis Sci 52: 8657-8664.
51. Vimaleswaran KS, Radha V, Ghosh S, Majumder PP, Rao MR, &, Mohan V, (2010): A haplotype at the UCP1 gene locus contributes to genetic risk for type 2 diabetes in Asian Indians (CURES-72). Metab Syndr Relat Disord 8: 63-68.
52. Wang J, Zhang RY, Chen RP, Sun J, Yang R, Ke XY, Chen H, &, Cai DH, (2013): Prevalence and risk factors for diabetic retinopathy in a high-risk Chinese population. BMC Public Health 13: 633.
53. Wong TY, Cheung N, Tay WT, et al. (2008): Prevalence and risk factors for diabetic retinopathy: the Singapore Malay Eye Study. Ophthalmology 115: 1869-1875.
54. Yudkin JS, (1999): Abnormalities of coagulation and fibrinolysis in insulin resistance. Evidence for a common antecedent?. Diabetes Care 22 (Suppl 3): C25-C30.
55. Zietz B, Barth N, Spiegel D, Schmitz G, Scholmerich J, &, Schaffler A, (2002): Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma2 (PPARgamma2) is associated with higher levels of total cholesterol and LDL-cholesterol in male caucasian type 2 diabetes patients. Exp Clin Endocrinol Diabetes 110: 60-66.